Drug-Drug Interaction Study to Investigate the Effect of Ketoconazole on the Pharmacokinetic Properties of CKD-501 in Healthy Male Volunteer: Open, Randomised, 2-way Crossover, Clinical Trial.
Phase of Trial: Phase I
Latest Information Update: 28 Jun 2011
At a glance
- Drugs Lobeglitazone (Primary) ; Ketoconazole
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 28 Jun 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 28 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.